LATE–a novel sensitive cell-based assay for the study of CRISPR/Cas9-related long-term adverse treatment effects

por Głów, Dawid, Meyer, Simon, García Roldán, Irene, Akingunsade, Lara Marie, Riecken, Kristoffer, Fehse, Boris
Publicado 2021